Jpmorgan Chase & CO Rockwell Medical, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 47,074 shares of RMTI stock, worth $114,860. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,074
Previous 35
134397.14%
Holding current value
$114,860
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RMTI
# of Institutions
63Shares Held
9.46MCall Options Held
339KPut Options Held
43.3K-
Armistice Capital, LLC New York, NY3.58MShares$8.74 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.2MShares$2.94 Million0.0% of portfolio
-
Globeflex Capital L P San Diego, CA743KShares$1.81 Million0.29% of portfolio
-
Marshall Wace, LLP London, X0509KShares$1.24 Million0.0% of portfolio
-
Perkins Capital Management Inc350KShares$854,9171.37% of portfolio
About ROCKWELL MEDICAL, INC.
- Ticker RMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 10,675,200
- Market Cap $26M
- Description
- Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...